Evidence map›Paper›PMID 34491321›Full record

ArticleJournal of Crohn's & colitis2022

The Effect of Phenotype and Genotype on the Plasma Proteome in Patients with Inflammatory Bowel Disease.

Arno R Bourgonje, Shixian Hu, Lieke M Spekhorst, Daria V Zhernakova, Arnau Vich Vila, Yanni Li, Michiel D Voskuil, Lisette A van Berkel, Brenda Bley Folly, Mohammed Charrout and 11 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of Crohn's & colitis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 38 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Anti-integrin αvβ6 Autoantibodies Are Increased in Primary Sclerosing Cholangitis Patients With Concomitant Inflammatory Bowel Disease and Correlate With Liver Disease Severity.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Fibroblast growth factor receptor 4 deficiency in macrophages aggravates experimental colitis by promoting M1-polarization.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Omics and Multi-Omics in IBD: No Integration, No Breakthroughs.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 4 institutions in 2 countries.

Arno R BourgonjeDepartment of Gastroenterology and Hepatology, University Medical Center Groningen, Groningen, The Netherlands.
Shixian HuDepartment of Gastroenterology and Hepatology, University Medical Center Groningen, Groningen, The Netherlands.
Lieke M SpekhorstDepartment of Gastroenterology and Hepatology, University Medical Center Groningen, Groningen, The Netherlands.
Daria V ZhernakovaDepartment of Genetics, University Medical Center Groningen, Groningen, The Netherlands.
Arnau Vich VilaDepartment of Gastroenterology and Hepatology, University Medical Center Groningen, Groningen, The Netherlands.
Yanni LiDepartment of Gastroenterology and Hepatology, University Medical Center Groningen, Groningen, The Netherlands.
Michiel D VoskuilDepartment of Gastroenterology and Hepatology, University Medical Center Groningen, Groningen, The Netherlands.
Lisette A van BerkelDepartment of Pediatrics, Division of Gastroenterology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Brenda Bley FollyDepartment of Pediatrics, Division of Gastroenterology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Mohammed CharroutDelft Bioinformatics Lab, Delft University of Technology, Delft, The Netherlands.ORCID 0000-0002-3405-1995
Ahmed MahfouzDelft Bioinformatics Lab, Delft University of Technology, Delft, The Netherlands.
Marcel J T ReindersDelft Bioinformatics Lab, Delft University of Technology, Delft, The Netherlands.ORCID 0000-0002-1148-1562
Julia I P van HeckDepartment of Internal Medicine and Radboud Institute of Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Leo A B JoostenDepartment of Internal Medicine and Radboud Institute of Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Marijn C VisschedijkDepartment of Gastroenterology and Hepatology, University Medical Center Groningen, Groningen, The Netherlands.
Hendrik M van DullemenDepartment of Gastroenterology and Hepatology, University Medical Center Groningen, Groningen, The Netherlands.
Klaas Nico FaberDepartment of Gastroenterology and Hepatology, University Medical Center Groningen, Groningen, The Netherlands.
Janneke N SamsomDepartment of Pediatrics, Division of Gastroenterology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Eleonora A M FestenDepartment of Gastroenterology and Hepatology, University Medical Center Groningen, Groningen, The Netherlands.
Gerard DijkstraDepartment of Gastroenterology and Hepatology, University Medical Center Groningen, Groningen, The Netherlands.
Rinse K WeersmaDepartment of Gastroenterology and Hepatology, University Medical Center Groningen, Groningen, The Netherlands.
University Medical Center Groningen · NLErasmus MC · NLLeiden University Medical Center · NLRadboud University Nijmegen · NL

Funding

Nederlandse Organisatie voor Wetenschappelijk Onderzoek 194.006Samenwerkende GezondheidsfondsenTakeda CanadaUniversity of Groningen 17-57
6 · The paper itself

Abstract

BACKGROUND AND

aimsProtein profiling in patients with inflammatory bowel diseases [IBD] for diagnostic and therapeutic purposes is underexplored. This study analysed the association between phenotype, genotype, and the plasma proteome in IBD.

methodsA total of 92 inflammation-related proteins were quantified in plasma of 1028 patients with IBD (567 Crohn's disease [CD]; 461 ulcerative colitis [UC]) and 148 healthy individuals to assess protein-phenotype associations. Corresponding whole-exome sequencing and global screening array data of 919 patients with IBD were included to analyse the effect of genetics on protein levels (protein quantitative trait loci [pQTL] analysis). Intestinal mucosal RNA sequencing and faecal metagenomic data were used for complementary analyses.

resultsThirty-two proteins were differentially abundant between IBD and healthy individuals, of which 22 proteins were independent of active inflammation; 69 proteins were associated with 15 demographic and clinical factors. Fibroblast growth factor-19 levels were decreased in CD patients with ileal disease or a history of ileocecal resection. Thirteen novel cis-pQTLs were identified and 10 replicated from previous studies. One trans-pQTL of the fucosyltransferase 2 [FUT2] gene [rs602662] and two independent cis-pQTLs of C-C motif chemokine 25 [CCL25] affected plasma CCL25 levels. Intestinal gene expression data revealed an overlapping cis-expression [e]QTL-variant [rs3745387] of the CCL25 gene. The FUT2 rs602662 trans-pQTL was associated with reduced abundances of faecal butyrate-producing bacteria.

conclusionsThis study shows that genotype and multiple disease phenotypes strongly associate with the plasma inflammatory proteome in IBD, and identifies disease-associated pathways that may help to improve disease management in the future.

Indexed as

Colitis, UlcerativeInflammatory Bowel DiseasesCase-Control StudiesGenotypeHumansPhenotypeProteomeProteomegeneticsInflammatory bowel diseaseproteomics

Identifiers

PMID34491321
PMCPMC8919819
OpenAlexW3169755981

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.